![]() |
Page History
Multiexcerpt | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Complete the following procedure for a Complete trial if it includes an Investigational New Drug (IND) or Investigational Device Exemption (IDE) as per US Food and Drug Administration regulations. If the trial was registered without IND/IDE information, you can provide it here. IND/IND information is optional for Abbreviated trials.
The choice of values for some fields in this section depend on values that you have selected in preceding fields. For example, if the Holder type is anything other than "NIH" or "NCI", NIH Institution / NCI Division/Program names are not available for selection. How to Abstract IND/IDE Information
|